-
J&J bids to extend prostate cancer uses for Akeega
07 Jul 2025 09:57 GMT
… a new indication in prostate cancer that could broaden use … treat metastatic castration-resistant prostate cancer (mCRPC), but J… with metastatic castration-sensitive prostate cancer (mCSPC), thanks to … given on top of prednisone or prednisolone. There was …
-
AB Science receives US FDA & EMA authorization for confirmatory phase 3 trial of masitinib in metastatic castrate resistant prostate cancer
07 Jul 2025 05:39 GMT
… masitinib in metastatic castrate resistant prostate cancer (study AB22007) has been … in metastatic castrate-resistant prostate cancer. With a validated biomarker … mg/m² plus prednisone for up to 10 cycles … mg/m² plus prednisone for up to 10 cycles …
-
What To Know About Metastatic Prostate Cancer
06 Jul 2025 14:17 GMT
… Prostate Cancer Symptoms
Prostate cancer may … Deltasone (prednisone) to … prostate cancer. Screening tests may catch prostate cancers … prostate cancer spread?
Prostate cancer is usually considered a slow-growing cancer, but metastatic prostate cancer …
-
JnJ seeks indication extension of Akeega from EMA for adults with metastatic hormone-sensitive prostate cancer, HRR gene alterations
06 Jul 2025 11:04 GMT
… niraparib and abiraterone acetate) with prednisone or prednisolone for the treatment … patients with metastatic hormone-sensitive prostate cancer (mHSPC) and homologous recombination … and abiraterone acetate plus prednisone or prednisolone is consistent …
-
AB Science: Masitinib receives FDA and EMA authorization for confirmatory phase 3 trial in metastatic castrate-resistant prostate cancer
04 Jul 2025 06:01 GMT
… IN METASTATIC CASTRATE-RESISTANT PROSTATE CANCER, WITH BIOMARKER-DRIVEN … in metastatic castrate resistant prostate cancer (study AB22007) has … /m² plus prednisone for up to 10 … [1] Cancer stat facts: prostate cancer. National Cancer Institute/ …
-
Upfront Combos Show Promise in Prostate Cancer, But Questions Remain
27 Jun 2025 18:00 GMT
… ) plus prednisone for the treatment of metastatic castration-sensitive prostate cancer fitting into …
-
Urinary Tract Microbiota Undermine Prostate Cancer Therapy
27 Jun 2025 05:31 GMT
… the growth of prostate cancer, substantially broadening current … –dependent proliferation of prostate cancer cells in vitro. … with prostate cancer unresponsive to standard abiraterone and prednisone therapy … tract in primary prostate cancer is warranted.”
Future …
-
Prostate Cancer Highlights From ASCO 2025
24 Jun 2025 18:18 GMT
Key findings on prostate cancer treatment from the 2025 ASCO … acetate plus prednisone (AAP) in patients with metastatic castration-sensitive prostate cancer. The …
-
Secondary Analysis of PSA and BCR-Free Survival in Asian Prostate Cancer Patients
23 Jun 2025 12:52 GMT
… prostate tumors with TP53 alterations (present in approximately 46% of primary prostate cancer … -sensitive prostate cancer treated with abiraterone acetate plus prednisone or … of 2024 in prostate cancer and prostatic diseases. Prostate Cancer Prostatic Dis. …
-
Dr Morgans Provides Prostate Cancer Updates From ASCO 2025
23 Jun 2025 00:16 GMT
… and prednisone (AAP) in patients with metastatic castration-sensitive prostate cancer … the metastatic hormone-sensitive prostate cancer setting. For those patients … acetate plus prednisone (AAP) for metastatic castration-sensitive prostate cancer (mCSPC) …